Moreover, a study conducted on HCT116 colon cancer cell line showed that resveratrol can reverse oxaliplatin-induced survivin suppression in HCT116 cells, restoring survivin expression at both mRNA and protein level, and pled for caution when using resveratrol with oxaliplatin in clinical practice [66]. Here, BIRC5 is linked to malignant colon neoplasm.